News – Page 610 – Endpoints News

Amgen's Otezla notches another PhIII win; Califf earns advocacy groups' stamp of approval

4 years ago

With generic competition heating up, Vas Narasimhan outlines Novartis' growth plans at R&D day

4 years ago

A Seattle biotech offloads lead eye drug in deal valued at $1B+ as it refocuses on emerging pipeline

4 years ago

A quiet Czech biotech bags $315M to drive its blossoming cancer pipeline through the clinic

4 years ago

As Omicron spread looms, oral antivirals appear to be one of the best defenses — now we just need more

4 years ago

Can the antibody-drug conjugate model work for NK cells? Acepodia loads up with another $109M to find out

4 years ago

Inmate who posed as AbbVie purchasing officer in $3M scam sentenced to 7 more years of prison

4 years ago

Watch out, Roche: Novartis inks $1.5B deal to chase down prominent Parkinson’s target

4 years ago

Amgen halts some drug discounts for safety net hospitals as SCOTUS takes on 340B case

4 years ago

Bob Nelsen woos John Maraganore to his first VC post after retiring from Alnylam

4 years ago

Another epigenome editing startup launches from a pair of the field’s longtime leaders

4 years ago

GlaxoSmithKline, Oxford unveil new partnership pitting buzzy R&D advances against neurological disease

4 years ago

With only burns to show in gene therapy, Astellas inks deal with AAV specialist Dyno in push for a better capsid

4 years ago

J&J and Sanofi's multiple myeloma tit-for-tat continues, as subcutaneous Darzalex wins combo approval

4 years ago

As first Omicron case in US crops up, researchers wonder: Which antibodies, vaccines will hold up?

4 years ago

GlaxoSmithKline's friendly ‘shark tank’ crowdsources ideas for multiple myeloma, kicks off bigger push

4 years ago

Statera Biopharma gets the OK to resume the study of a potential stockpile drug for lethal radiation exposure

4 years ago

Can South Dakota's transgenic cows help treat the flu?; A speedy review for Merck's Prevnar rival in kids

4 years ago

Moderna loses latest battle in key vaccine delivery patent fight as federal appeal falls flat

4 years ago

VBI Vaccines execs tout approval of new triple-antigen hepatitis B shot. Can they sell it?

4 years ago

Months after shocking investors with lung cancer win, BeyondSpring's lead drug hits roadblock at the FDA

4 years ago

What's fair? New ICER report shows payers generally ensuring fair access to drugs

4 years ago

Battling a lineup of skeptics, Vertex claims another early clinical win — this time in kidney disease

4 years ago

China boasts 48% price cut on insulin as domestic drugmakers eclipse Big Pharma in bulk order

4 years ago

First page Previous page 607 608 609610611 612 613 Next page Last page